Response to Comment on: Greenbaum et al. Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite type 1 diabetes TrialNet data. Diabetes 2012;61:2066-2073

Comment

Carla J Greenbaum et al. Diabetes. 2013 Jun.

. 2013 Jun;62(6):e8.

doi: 10.2337/db13-0115.

No abstract available

Comment on

Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data.
Greenbaum CJ, Beam CA, Boulware D, Gitelman SE, Gottlieb PA, Herold KC, Lachin JM, McGee P, Palmer JP, Pescovitz MD, Krause-Steinrauf H, Skyler JS, Sosenko JM; Type 1 Diabetes TrialNet Study Group. Greenbaum CJ, et al. Diabetes. 2012 Aug;61(8):2066-73. doi: 10.2337/db11-1538. Epub 2012 Jun 11. Diabetes. 2012. PMID: 22688329 Free PMC article.
Comment on: Greenbaum et al. Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite type 1 Diabetes TrialNet data. Diabetes 2012;61:2066-2073.
Rios P, de Hollanda A, Giménez M, Conget I. Rios P, et al. Diabetes. 2013 Jun;62(6):e7. doi: 10.2337/db13-0047. Diabetes. 2013. PMID: 23704534 Free PMC article. No abstract available.

1. Rios P, de Hollanda A, Giménez M, Conget I. Comment on: Greenbaum et al. Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data. Diabetes 2012;61:2066–2073 (Letter). Diabetes 2013;62:e7 DOI: 10.2337/db13-0047 - PMC - PubMed
1. Greenbaum CJ, Beam CA, Boulware D, et al. ; Type 1 Diabetes TrialNet Study Group Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data. Diabetes 2012;61:2066–2073 - PMC - PubMed